These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice. Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235 [TBL] [Abstract][Full Text] [Related]
5. Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin content. Füchtenbusch M; Larger E; Thebault K; Boitard C Horm Metab Res; 2005 Feb; 37(2):63-7. PubMed ID: 15778920 [TBL] [Abstract][Full Text] [Related]
6. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase. Jun HS; Chung YH; Han J; Kim A; Yoo SS; Sherwin RS; Yoon JW Diabetologia; 2002 May; 45(5):668-76. PubMed ID: 12107747 [TBL] [Abstract][Full Text] [Related]
7. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway. Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677 [TBL] [Abstract][Full Text] [Related]
8. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. Qin HY; Sadelain MW; Hitchon C; Lauzon J; Singh B J Immunol; 1993 Mar; 150(5):2072-80. PubMed ID: 8436836 [TBL] [Abstract][Full Text] [Related]
9. Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes. Bergerot I; Fabien N; Maguer V; Thivolet C J Autoimmun; 1994 Oct; 7(5):655-63. PubMed ID: 7840857 [TBL] [Abstract][Full Text] [Related]
10. Human LT-alpha-mediated resistance to autoimmune diabetes is induced in NOD, but not NOD-scid, mice and abrogated by IL-12. Miyaguchi S; Satoh J; Takahashi K; Sakata Y; Nakazawa T; Miyazaki J; Toyota T Clin Immunol; 2001 Jan; 98(1):119-24. PubMed ID: 11141334 [TBL] [Abstract][Full Text] [Related]
11. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model. Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153 [TBL] [Abstract][Full Text] [Related]
12. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes. Ogawa N; Minamimura K; Kodaka T; Maki T J Autoimmun; 2006 Jun; 26(4):225-31. PubMed ID: 16713179 [TBL] [Abstract][Full Text] [Related]
13. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae. Saï P; Rivereau AS Diabetes Metab; 1996 Oct; 22(5):341-8. PubMed ID: 8896996 [TBL] [Abstract][Full Text] [Related]
14. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1. Moritani M; Yoshimoto K; Wong SF; Tanaka C; Yamaoka T; Sano T; Komagata Y; Miyazaki J; Kikutani H; Itakura M J Clin Invest; 1998 Aug; 102(3):499-506. PubMed ID: 9691086 [TBL] [Abstract][Full Text] [Related]
15. Lymphoid hyperplasia, CD45RBhigh to CD45RBlow T-cell imbalance, and suppression of Type I diabetes mellitus result from TNF blockade in NOD-->NOD-scid adoptive T cell transfer. Brown GR; Silva MD; Thompson PA; Beutler B Diabetologia; 1998 Dec; 41(12):1502-10. PubMed ID: 9867218 [TBL] [Abstract][Full Text] [Related]
16. B7-H4.Ig inhibits the development of type 1 diabetes by regulating Th17 cells in NOD mice. Lee IF; Wang X; Hao J; Akhoundsadegh N; Chen L; Liu L; Langermann S; Ou D; Warnock GL Cell Immunol; 2013 Mar; 282(1):1-8. PubMed ID: 23623902 [TBL] [Abstract][Full Text] [Related]
17. Targeting of a T cell agonist peptide to lysosomes by DNA vaccination induces tolerance in the nonobese diabetic mouse. Rivas EI; Driver JP; Garabatos N; Presa M; Mora C; Rodriguez F; Serreze DV; Stratmann T J Immunol; 2011 Apr; 186(7):4078-87. PubMed ID: 21346228 [TBL] [Abstract][Full Text] [Related]
18. Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice. You S; Slehoffer G; Barriot S; Bach JF; Chatenoud L Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14580-5. PubMed ID: 15340148 [TBL] [Abstract][Full Text] [Related]
19. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes. Bergerot I; Fabien N; Thivolet C Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168 [TBL] [Abstract][Full Text] [Related]
20. NOD fetal thymus organ culture: an in vitro model for the development of T cells involved in IDDM. Wilson SS; DeLuca D J Autoimmun; 1997 Oct; 10(5):461-72. PubMed ID: 9376074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]